OJD  Vol.5 No.4 , November 2016
Treating Depression with the Mephenesin Analog Skeletal Muscle Relaxant Methocarbamol
Show more
Abstract: It is difficult to treat depression because there is no established method for treatment. Many drugs have been developed by Pharmaceutical companies to treat depression. Depression affects many patients. It was necessary to focus on “meprobamate” which was once said to be a magic drug. It was found that “methocarbamol” is more suitable for treating depression than “meprobamate”.
Cite this paper: Numazawa, T. (2016) Treating Depression with the Mephenesin Analog Skeletal Muscle Relaxant Methocarbamol. Open Journal of Depression, 5, 40-47. doi: 10.4236/ojd.2016.54005.

[1]   Yamauchi, T., Kojima, T., Kurachi, M. and Kashima, H. (2011) Psychiatry of People Aimed at Specialist. Ver. 3, Igaku-Shoin, 610-611.

[2]   Matsueda, A. (2010) Epidemic of Tranquilizers. Core Ethics, 6, 387, 390-395.

[3]   Miyano, S., Watanabe, K. and Sumoto, K. (2000) Medicinal Chemistry Structure-Activity Relationship of Clinical Pharmacy and Medicine [I]. Hirokawa Shoten, 147.

[4]   Nagatomo, T., Kunitomo, M., Hagiwara, M. and Takeda, H. (2008) Medical Pharmacy Latest Pharmacology. Ver. 9, Hirokawa Shoten, 117.

[5]   Numazawa, T. (2016) Principle of and Medical Treatment for Depression. Science Metters.

[6]   Nakamura, T., Sirogami, M. and Kimura, K. (2009) Regulatory Laws and System Manual. Ver. 9, Nanzandou, 98.

[7]   Campbell, D.J., Sherbaniuk, R. and Rigby, J. (1964) False Positive Reaction due to Methocarbamol in the Screening Test for Vanilmandelic Acid (VMA). Clinical Chemistry, 10, 447-450.

[8]   Takahashi, S. and Takahashi, K. (1984) Pharmacology and Biochemistry of Psychiatric Disorders. Japanese Ver., Richard Green, A. and Costain, D.W. (Translator), Nishimura Shoten, 80.

[9]   KEGG DRUG Database Kanehisa Laboratories.

[10]   Porsolt, R.D., Bertin, A. and Jalfre, M. (1977) Behavioral Despair in Mice: A Primary Screening Test for Antidepressants. Archives Internationales de Pharmacodynamie et de Therapie, 229, 327-336.